quest
order
simplic
often
dissect
complex
diseas
syndrom
simpler
compon
articl
discuss
caus
agent
pathogenesi
therapeut
agent
separ
howev
hasten
remind
reader
realiti
diseas
seldom
simplist
instead
mani
case
outbreak
neonat
diarrhea
associ
multipl
pathogen
pathogen
caus
diarrhea
one
mechan
case
import
know
etiolog
agent
specif
therapi
direct
case
nonspecif
symptomat
support
therapi
altern
although
therapi
direct
specif
pathogen
known
suspect
involv
greatest
success
treat
diarrheic
calv
come
treatment
regimen
revers
pathophysiolog
abnorm
associ
diarrhea
calv
regardless
caus
instanc
import
know
diarrheacaus
agent
other
escherichia
coli
salmonella
sp
giardia
duodenali
respond
specif
therapi
wherea
virus
cryptosporidium
muri
cryptosporidia
caus
diseas
human
be
howev
import
establish
diagnosi
organ
instanc
treatment
singl
patient
initi
treatment
herd
outbreak
must
initi
without
confirm
etiolog
diagnosi
medic
histori
herd
age
onset
diarrhea
characterist
fece
accompani
clinic
sign
often
use
establish
presumpt
etiolog
diagnosi
therapi
direct
specif
known
suspect
pathogen
howev
therapeut
success
achiev
consist
regimen
use
revers
pathophysiolog
abnorm
regardless
caus
infect
entereotoxigen
e
coli
etec
caus
acut
sever
wateri
diarrhea
dehydr
often
result
death
calv
younger
day
age
sever
case
occur
calv
younger
week
age
caus
diarrhea
etec
must
possess
adher
factor
pili
secret
enterotoxin
frequent
identifi
type
pilu
also
known
although
also
found
etec
calv
thermost
enterotoxin
sta
produc
etec
isol
calv
diagnosi
colibacillosi
confirm
isol
e
coli
fece
identifi
pilu
antigen
small
percentag
etec
may
possess
pilu
antigen
caus
diseas
encount
infrequ
suspect
etec
isol
clinic
sign
signal
typic
colibacillosi
rememb
e
coli
may
isol
almost
everi
calf
world
escherichia
coli
normal
inhabit
mammalian
larg
intestin
isol
fece
without
identif
pilu
antigen
enterotoxin
littl
pathogen
signific
misunderstand
fact
led
tremend
misus
antimicrobi
drug
diarrheic
calv
salmonella
sp
serotyp
salmonella
four
isol
frequent
cattl
typhimurium
dublin
muenchen
copenhagen
unlik
etec
salmonella
invas
calv
day
month
age
suscept
salmonellosi
salmonella
invas
sever
mucos
damag
infect
lymph
node
bacteremia
may
result
fece
vari
slightli
loos
volumin
may
foulsmel
blood
strand
fibrin
mucu
contrast
caus
diarrhea
neonat
calv
salmonellosi
often
caus
fever
anorexia
depress
without
concomit
dehydr
bacteria
enteropathogen
e
coli
recent
isol
calv
enterocol
bacteria
also
call
attach
effac
adher
close
enterocyt
effac
microvilli
attach
site
strain
produc
shigellalik
toxin
produc
enterotoxin
lesion
primarili
colon
dysenteri
promin
clinic
sign
preval
import
pathogen
caus
diarrhea
calv
unknown
campylobact
jejuni
isol
calv
diarrhea
infect
experiment
calv
result
mild
diarrhea
howev
frequenc
isol
c
jejuni
diarrheic
healthi
calv
differ
therefor
signific
bacterium
caus
clinic
diseas
calv
question
thought
nonpathogen
protozoa
cryptosporidium
mum
consid
major
contribut
caus
outbreak
diarrhea
calv
week
age
preval
infect
dairi
farm
high
one
studi
infect
alway
caus
diarrhea
natur
infect
calv
ileum
distal
jejunum
site
infect
lesion
consist
villou
blunt
infiltr
lamina
propria
inflammatori
cell
bridg
adjac
villi
concurr
infect
virus
common
therefor
fecal
characterist
variabl
one
author
ajr
observ
sever
calv
physic
hematolog
biochem
abnorm
consist
malnutrit
malabsorpt
due
sever
villou
atrophi
calv
week
age
emaci
comatos
hypoglycem
andor
hypotherm
mildli
moder
dehydr
dramat
temporarili
respond
intraven
administ
glucos
andor
restor
bodi
temperatur
cryptosporidia
observ
fece
calv
usual
mucoid
loos
volumin
wateri
cryptosporidi
oocyst
extrem
resist
environ
disinfect
mammal
includ
human
suscept
infect
immunocompet
peopl
sign
infect
mild
moder
diarrhea
flulik
symptom
cryptosporidiosi
disabl
fatal
immunocompromis
peopl
includ
patient
aid
receiv
immunosuppress
drug
radiat
therapi
forth
giardia
duodena
li
flagel
protozoa
found
small
intestin
sever
domest
speci
includ
cattl
natur
infect
calv
rang
age
day
week
clinic
sign
includ
diarrhea
sometim
becam
chronic
mucoid
fece
poor
weight
gain
diseas
transmit
experiment
inocul
oocyst
calv
virus
frequent
caus
diarrhea
neonat
calv
although
rotaviru
coronaviru
familiar
viral
pathogen
calicilik
parvoviru
isol
diarrheic
calv
caus
diarrhea
experiment
calv
signific
preval
viral
diarrhea
yet
determin
less
known
virus
receiv
littl
attent
diagnost
laboratori
preval
probabl
underestim
viral
infect
occur
almost
age
herd
immun
environment
contamin
may
import
determin
age
onset
particular
herd
rotaviru
usual
affect
younger
calv
day
week
caus
mild
moder
diarrhea
complic
villou
atrophi
first
occur
orad
half
jejunum
later
spread
rest
small
intestin
coronaviru
result
seriou
diseas
affect
grater
portion
villu
propens
infect
larg
intestin
well
small
intestin
bredaviru
also
caus
lesion
small
larg
intestin
clinic
sign
viral
enter
nonspecif
includ
waterytomucoid
diarrhea
without
blood
dehydr
depress
import
determin
specif
viral
pathogen
involv
case
outbreak
diarrhea
debat
specif
therapi
current
avail
efficaci
viral
vaccin
question
consid
therapeut
strategi
ident
viru
involv
diarrhea
rel
unimport
follow
argument
commit
signific
resourc
attempt
identifi
viral
pathogen
specif
antivir
therapi
current
avail
intermitt
shed
mix
infect
render
difficult
isol
potenti
viral
pathogen
involv
virus
almost
ubiquit
isol
calv
outbreak
diarrhea
calv
older
week
identif
viral
pathogen
may
import
prevent
especi
highli
effect
vaccin
develop
therapeut
standpoint
diagnost
effort
may
direct
toward
identif
pathogen
would
indic
need
alter
therapeut
protocol
name
etec
salmonella
giardia
cryptosporidium
zoonot
potenti
mani
adject
secretori
osmot
malabsorpt
maldigest
nutrit
use
describ
type
diarrhea
base
patholog
mechan
simpl
yet
complet
scheme
classifi
diarrhea
accord
mechan
propos
argenzio
easili
adapt
discuss
therapi
use
classif
present
enterotoxin
proven
import
caus
diarrhea
calv
sta
e
coli
sta
induc
net
secret
na
clbi
activ
guanyl
cyclas
role
intracellular
ca
calmodulin
still
controversi
releas
arachidon
acid
format
prostaglandin
also
may
occur
naclcotransport
system
enterocyt
membran
disabl
sta
membranebound
naglucos
cotransport
system
remain
function
provid
excel
opportun
util
na
glucos
oral
administ
rehydr
solut
enhanc
water
absorpt
although
major
lesion
caus
etec
biochem
morpholog
chang
report
howev
gener
absorpt
capac
intestin
probabl
less
affect
etec
pathogen
enterotoxin
isol
strain
salmonella
typhimurium
equin
origin
reason
suspect
salmonella
bovin
origin
also
may
elabor
enterotoxin
inflamm
probabl
compon
pathophysiolog
nearli
infecti
diarrhea
invas
organ
salmonella
incit
intens
inflammatori
respons
virus
cryptosporidia
howev
previous
cite
even
etecinduc
diarrhea
may
inflammatori
compon
sever
mediat
inflamm
includ
histamin
prostaglandin
effect
intestin
transmembran
ionic
flux
probabl
involv
pathogenesi
diarrhea
induc
inflamm
accompani
inflamm
loss
disrupt
normal
villou
architectur
enterocyt
necrosi
submucos
inflammatori
infiltr
villou
atrophi
contribut
malabsorpt
salmonellosi
villou
atrophi
fuse
villi
inflammatori
cell
infiltr
typic
lesion
caus
virus
cryptosporidia
brushbord
enzym
particularli
lactas
lost
lactos
degrad
small
intestin
likewis
nutrient
absorb
small
intestin
villou
atrophi
occur
undigest
nutrient
enter
larg
intestin
becom
substrat
colon
bacteria
degrad
larg
molecul
small
one
osmot
effect
particl
exacerb
diarrhea
organ
acid
produc
colon
ferment
fece
malabsorpt
diarrhea
often
acid
villou
atrophi
caus
viral
bacteri
protozo
enter
infect
result
decreas
intestin
surfac
area
absorpt
addit
brushbord
enzym
locat
tip
normal
villu
lack
result
maldigest
sever
maldigest
malabsorpt
relat
sever
villou
atrophi
locat
extent
lesion
gut
diarrhea
due
malabsorpt
maldigest
result
passag
undigest
food
colon
follow
bacteri
ferment
pure
malabsorpt
diarrhea
elimin
fast
patient
howev
infecti
diarrhea
calv
pure
malabsorpt
diarrhea
seldom
exist
sever
villou
atrophi
like
alter
absorpt
drug
gut
author
unawar
studi
use
calv
demonstr
phenomenon
system
concentr
drug
desir
howev
advis
reli
oral
administ
drug
calv
diarrhea
addit
infecti
caus
villou
atrophi
antimicrobi
agent
also
caus
malabsorpt
healthi
calv
day
oral
treatment
therapeut
dose
chloramphenicol
neomycin
ampicillin
tetracyclin
calv
develop
diarrhea
abnorm
oral
glucos
toler
test
microscop
evid
villou
atrophi
addit
lack
antidiarrh
efficaci
antimicrobi
drug
villou
atrophi
produc
compound
anoth
reason
avoid
oral
administ
antimicrobi
treat
diarrheic
calv
without
doubt
intestin
motil
alter
anim
peopl
diarrhea
howev
much
confus
chang
motil
associ
diarrhea
small
intestin
diarrhea
associ
prolong
phase
ii
migrat
myoelectr
complex
mmc
appear
minut
rhythm
disorgan
none
phenomena
view
decreas
intestin
motil
howev
diarrhea
associ
decreas
short
spike
burst
colon
thought
stationari
contract
imped
segment
contract
present
colon
normal
even
infrequ
long
spike
burst
peristalt
contract
capabl
move
ingesta
rapidli
colon
therefor
singl
dogmat
statement
increas
decreas
motil
diarrhea
appli
entir
intestin
tract
gener
accept
hypermotil
seldom
signific
caus
diarrhea
drug
gener
inhibit
intestin
motil
seldom
indic
part
antidiarrh
therapi
section
discuss
pharmacolog
manag
calv
diarrhea
perhap
appropri
focu
logic
manag
patient
seem
veterinarian
sometim
get
preoccupi
pharmaco
forget
logic
treatment
sever
impedi
success
treatment
diarrheal
diseas
calv
firstli
seldom
advantag
know
exact
etiolog
agent
least
commenc
therapi
even
resourc
avail
physician
etiolog
diagnosi
accomplish
fewer
half
human
diarrheic
patient
furthermor
even
know
etiolog
agent
pathogen
direct
specif
therapi
name
ete
salmonella
giardia
second
impedi
success
treatment
incomplet
understand
pathogenesi
diarrhea
except
secretori
diarrhea
associ
ete
mechan
welldefin
rel
import
inflamm
variou
mediat
pertub
gut
hormon
motil
unknown
final
excess
emphasi
charact
quantiti
fece
rather
gener
condit
patient
impedi
interest
perspect
present
ludan
infecti
enter
acut
diarrhea
per
se
cleans
effect
physiolog
benefici
effect
acut
dehydr
accompani
diarrhea
patholog
unfortun
bovin
practic
abl
routin
suppli
necessari
support
care
maintain
calv
diarrhea
run
cours
calf
intestin
heal
therefor
search
continu
cure
diarrhea
although
may
prove
lifesav
also
rememb
extrem
success
antidiarrh
agent
may
seriou
side
effect
diarrhea
fact
benefici
physiolog
process
beyond
scope
articl
discuss
principl
fluid
therapi
diarrheic
calv
howev
essenti
rememb
replac
fluid
electrolyt
cornerston
medic
manag
diarrheic
calf
calv
diarrhea
therapi
necessari
therefor
comment
pharmacolog
manag
diarrhea
made
assumpt
fluid
electrolyt
replac
first
therapeut
prioriti
accomplish
complet
discuss
fluid
therapi
cattl
pleas
refer
veterinari
clinic
north
america
food
anim
practic
march
wide
use
probabl
overus
drug
treatment
diarrhea
calv
undoubtedli
antimicrobi
agent
first
identifi
caus
diarrhea
calv
e
coli
e
coli
isol
nearli
everi
diarrheic
calf
therefor
seem
sensibl
treat
everi
diarrheic
calf
antimicrobi
drug
effect
e
coli
understand
caus
pathophysiolog
diarrhea
calv
advanc
remark
fartoocommon
practic
owner
degre
veterinarian
treat
diarrheic
calv
antimicrobi
drug
reflect
advanc
high
incid
mildtomoder
selflimit
diarrhea
neonat
calv
perpetu
practic
administ
scour
pill
everi
calf
loos
fece
vast
major
case
selflimit
success
treatment
anyth
high
therefor
misus
goe
potenti
creat
highli
resist
bacteri
popul
increas
ete
noninvas
oral
rout
administr
antimicrobi
drug
prefer
anoth
bacteri
diseas
recogn
suspect
parenter
administr
antimicrobi
agent
also
recommend
extent
antimicrobi
absorb
across
diseas
intestin
known
therefor
one
reli
absorpt
oral
administ
antimicrobi
drug
achiev
adequ
system
concentr
drug
list
antimicrobi
agent
approv
unit
state
use
calv
diarrhea
although
result
vari
among
studi
e
coli
diarrheic
calv
appear
fairli
resist
vitro
approv
drug
tabl
fact
isol
studi
calv
previous
treat
antimicrobi
agent
may
bias
result
toward
greater
antimicrobi
resist
data
studi
show
gentamicin
nitrofuran
activ
greater
bovin
isol
enter
e
coli
two
report
suscept
bovin
isol
e
coli
exclus
diarrheic
calv
show
vitro
suscept
sulfachlorpyridazin
experiment
etec
infect
calv
cephamycin
c
amoxicillin
administ
oral
shown
reduc
treatment
calv
spontan
etec
sulfachlorpyridazin
administ
oral
result
surviv
one
author
ajr
success
halt
outbreak
etec
diarrhea
potenti
sulfonamid
mg
oral
twicedaili
first
day
life
product
contain
specif
antibodi
secur
human
etec
import
caus
travel
diarrhea
potenti
sulfonamid
doxycyclin
quinolon
prefer
drug
treatment
condit
effect
prevent
also
effect
reduc
durat
diarrhea
begun
salmonellosi
less
like
colibacillosi
pure
enter
diseas
calv
make
parenter
antimicrobi
therapi
ration
treatment
salmonellosi
object
antimicrobi
therapi
salmonellosi
elimin
organ
gut
elimin
diarrhea
caus
rather
elimin
system
infect
tabl
list
suscept
vitro
salmonella
isol
cattl
antimicrobi
drug
approv
parenter
use
cattl
unit
state
cephalothin
sulfachlorpyridazin
perhap
ampicillin
antimicrobi
drug
suffici
activ
vitro
recommend
use
patient
suspect
salmonellosi
await
result
suscept
test
organ
isol
patient
studi
isol
suscept
gentamicin
one
studi
suscept
potenti
sulfonamid
experiment
induc
salmonellosi
calv
trimethoprim
mgkg
sulfadiazin
mgkg
administ
either
intramuscularli
intraven
effect
reduc
mortal
challeng
organ
suscept
vitro
drug
one
studi
chronic
salmonellosi
children
respond
within
hour
initi
therapi
amikacin
either
nalidix
acid
norfloxacin
children
die
complic
day
diarrhea
resolv
anoth
studi
chronic
human
carrier
salmonella
treatment
potenti
sulfonamid
elimin
carrier
state
rapidli
treatment
wellcontrol
clinic
trial
evalu
efficaci
antimicrobi
agent
treatment
spontan
nonspecif
diarrhea
calv
scarc
two
treatment
antimicrobi
agent
benefici
wherea
third
benefit
realiz
sever
studi
acut
undifferenti
diarrhea
human
treatment
antimicrobi
agent
result
faster
resolut
clinic
sign
fewer
posttreat
posit
stool
cultur
interestingli
respons
treatment
differ
patient
pathogen
bacteria
isol
prior
treatment
neg
cultur
giardia
duo
dena
li
infect
dog
treat
oral
administr
metronidazol
quinacrin
milibi
furozolidin
follow
drug
use
treatment
giardiasi
cattl
reportedli
good
clinic
result
quinacrin
mgkg
oral
twice
daili
day
furazolidon
dimetridazol
mgkg
oral
twice
daili
none
drug
approv
treatment
foodproduc
anim
unit
state
number
drug
shown
antisecretori
activ
vitro
nonsteroid
antiinflammatori
drug
nsaid
alphaadrenerg
agonist
calcium
channel
blocker
opiat
phenothiazin
compound
reduc
net
loss
intestin
fluid
vitro
logic
nsaid
reduc
secret
result
prostaglandininduc
inflamm
howev
may
second
mechan
nsaid
decreas
diarrhea
salicyl
phenylbutazon
hunixin
meglumin
indomethacin
effect
reduc
secret
induc
enterotoxin
primarili
flunixin
meglumin
mgkg
iv
reduc
diarrhea
experiment
calv
challeng
live
etec
mgkg
intramuscularli
reduc
total
fecal
output
calv
receiv
partial
purifi
sta
intraven
administ
sodium
salicyl
oral
administ
aspirin
reduc
stainduc
secret
intestin
loop
experiment
calv
numer
studi
demonstr
benefit
bismuth
subsalicyl
prevent
treatment
diarrhea
human
propos
mechan
action
includ
bind
enterotoxin
prevent
attach
antimicrobi
activ
bismuth
antisecretori
activ
salicyl
bind
bile
acid
frequent
report
use
bismuth
sub
salicyl
prevent
treatment
travel
diarrhea
human
usual
dose
treatment
ml
everi
minut
dose
gener
bismuth
subsalicyl
effect
prevent
diarrhea
treat
author
report
improv
clinic
sign
human
receiv
bismuth
sub
salicyl
compar
receiv
placebo
one
therapeut
success
greater
patient
etec
isol
three
studi
loperamid
superior
bismuth
subsalicyl
bismuth
sub
salicyl
also
effect
treat
acut
chronic
diarrhea
children
although
wide
use
veterinari
medicin
bismuth
sub
salicyl
knowledg
evalu
control
clinic
trial
calv
alphaadrenerg
agonist
reduc
secret
decreas
intracellular
cyclic
adenosin
monophosph
lidamidin
agonist
demonstr
antisecretori
activ
porcin
model
use
sta
secretagogu
pig
anesthet
degre
sedat
produc
drug
evalu
clonidin
similar
agonist
reduc
diarrhea
incid
death
pig
experiment
induc
mix
viral
etec
enter
calcium
channel
blocker
diminish
net
effiux
ion
water
modul
concentr
intracellular
calcium
howev
stainduc
secret
may
mediat
ca
may
second
mechan
also
block
loperamid
sever
antidiarrh
properti
also
block
calcium
channel
wide
use
treat
diarrheic
patient
loperamid
well
opiat
revers
secretori
action
secretagogu
mechan
action
unknown
fact
tetrodotoxin
block
action
morphin
suggest
opiat
work
indirectli
neural
mechan
loperamid
market
overthecount
use
human
studi
mani
clinic
trial
welltoler
reduc
frequenc
defec
time
cessat
unform
stool
human
patient
acut
diarrhea
compar
diphenoxyl
plu
atropin
lomotil
attapulgit
bismuth
subsalicyl
loperamid
superior
knowledg
studi
evalu
antisecretori
effect
loperamid
conduct
use
calv
although
advers
effect
loperamid
minim
recommend
infant
associ
necrot
enterocol
two
loperamid
one
three
drug
avail
counter
unit
state
human
use
consid
safe
effect
food
drug
administr
fda
loperamid
littl
potenti
abus
diphenoxyl
atropin
anoth
opiat
proven
clinic
efficaci
atropin
ad
reduc
potenti
abus
product
comparison
studi
diphenoxyl
atropin
inferior
loperamid
adsorb
kaolin
clay
pectin
deriv
fruit
accept
treatment
diarrhea
human
be
well
domest
anim
although
kaolin
pectin
improv
consist
fece
reduc
loss
water
ion
fact
data
studi
use
rat
show
diarrheic
anim
receiv
kaolinpectin
lost
potassium
sodium
base
data
use
combin
kaolin
pectin
discourag
calv
deplet
potassium
frequent
featur
neonat
diarrhea
activ
attapulgit
anoth
three
drug
sold
counter
unit
state
use
human
patient
consid
safe
effect
fda
recent
studi
show
attapulgit
inferior
loperamid
treatment
acut
diarrhea
human
intuit
linkag
among
intestin
transit
time
fecal
volum
intestin
motil
led
veterinarian
physician
assum
reduc
intestin
motil
would
reduc
diarrhea
fact
induct
complet
intestin
paralysi
would
success
treatment
diarrhea
success
measur
term
fecal
product
cumul
effect
therapi
would
disastr
howev
reduc
motil
would
allow
accumul
toxin
pathogen
within
intestin
lumen
may
exacerb
toxigen
invas
enteritid
rememb
diarrhea
may
physiolog
dehydr
patholog
perhap
german
issu
modif
intestin
motil
diarrheic
patient
fact
pertub
motil
diarrheal
diseas
poorli
understood
easi
restor
physiolog
function
normalci
one
know
natur
abnorm
even
know
abnorm
exist
therefor
view
known
known
motil
diarrheal
diseas
author
recommend
anticholinerg
drug
paralyz
gut
treatment
diarrheal
diseas
opiat
howev
effect
antidiarrh
drug
previous
describ
anti
secretori
drug
loperamid
thought
exert
antidiarrh
effect
primarili
motil
modifi
properti
loperamid
induc
chang
motil
gastrointestin
tract
healthi
calv
attenu
chang
induc
mannitol
castor
oil
howev
delay
onset
diarrhea
induc
mannitol
castor
oil
author
studi
conclud
antidiarrh
effect
loperamid
due
effect
motil
chlorpromazin
phenothiazin
deriv
may
exert
antidiarrh
activ
effect
calmodulin
cyclic
amp
membran
stabil
reduct
stainduc
secret
diarrhea
demonstr
mice
piglet
durat
diarrhea
field
outbreak
diarrhea
piglet
shorten
piglet
receiv
mg
chlorpromazin
kg
bodi
weight
intramuscularli
higher
dose
experiment
pig
result
greater
efficaci
mark
sedat
occur
author
unawar
use
chlorpromazin
calv
niacin
nicotin
acid
shown
anti
secretori
experiment
entertoxigen
diarrhea
efficaci
disappoint
human
clinic
trial
berberin
extract
plant
use
centuri
far
east
treat
diarrheal
diseas
possess
antisecretori
antimicrobi
properti
human
patient
berberin
remark
reduc
fecal
volum
etecinduc
diarrhea
clinic
trial
netherland
disodium
cromoglyc
mg
fed
twice
daili
reduc
sever
diarrhea
veal
calv
nutmeg
fed
daili
calv
day
birth
credit
absenc
diarrhea
year
one
farm
acupunctur
found
equal
effect
gentamicin
treatment
undifferenti
diarrhea
piglet
equal
neomycin
treatment
etec
piglet
use
probiot
advoc
prevent
diarrhea
fed
diseas
present
aid
enhanc
recuper
fed
convalesc
theori
propos
explain
potenti
benefit
probiot
includ
alter
ph
intestin
lumen
product
enzym
b
vitamin
antibiot
alter
intestin
flora
competit
lactobacilli
reduc
popul
e
coli
small
intestin
mice
cellfre
broth
cultur
l
bulgaricu
show
signific
antientertoxin
activ
pig
wherea
str
fascium
broth
strong
inhibitori
activ
e
coli
sever
strain
littl
activ
toxin
organ
therefor
unwis
gener
probiot
unwis
gener
antibiot
appar
studi
use
commerci
product
contain
l
acidophilu
l
casei
torulopsi
aspergillu
convalesc
calv
fed
product
recoveri
diarrhea
gain
weight
receiv
product
summari
therapeut
strategi
treatment
diarrhea
neonat
calv
logic
target
correct
physiolog
dysfunct
appropri
specif
antimicrobi
antiprotozo
therapi
institut
colibacillosi
salmonellosi
giardiasi
confirm
suspect
calv
diarrhea
rehydr
necessari
proper
nutrit
support
provid
antisecretori
agent
flunixin
meglumin
bismuth
subsalicyl
may
benefici
treatment
calv
colibacillosi
salmonellosi
adsorb
attapulgit
bismuth
subsalicyl
also
may
reduc
loss
fluid
perhap
loperamid
similar
drug
proven
effect
calv
futur
potenti
harm
drug
includ
sever
antimicrobi
agent
administ
oral
result
malabsorpt
kaolin
pectin
increas
loss
ion
diarrhea
motil
modifi
caus
decreas
type
intestin
motor
function
final
success
measur
indic
product
surviv
day
treat
weight
gain
net
profit
goal
restor
maintain
health
calf
simpli
alter
volum
consist
fece
